Borealis Ventures

Avitide, Inc. specializes in the discovery, manufacture, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, the company focuses on developing customized affinity purification products that improve the efficiency and effectiveness of bioprocessing. Avitide's technology enhances the purification of therapeutic proteins, including enzymes, antibodies, gene therapies, and vaccines, by employing rapid development of chromatography resins through chemical synthesis. This advanced platform enables clients to accelerate bioprocess development timelines, mitigate program risks, and achieve predictable commercial scalability while lowering manufacturing costs in both batch and continuous operations.

Avitide, Inc. specializes in the discovery, manufacture, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, the company focuses on developing customized affinity purification products that improve the efficiency and effectiveness of bioprocessing. Avitide's technology enhances the purification of therapeutic proteins, including enzymes, antibodies, gene therapies, and vaccines, by employing rapid development of chromatography resins through chemical synthesis. This advanced platform enables clients to accelerate bioprocess development timelines, mitigate program risks, and achieve predictable commercial scalability while lowering manufacturing costs in both batch and continuous operations.

Adored, Inc. is a company based in Manchester, New Hampshire, that offers a mobile loyalty experience platform designed for restaurants, bars, coffee shops, ski resorts, and various attractions. The Adored app utilizes iBeacon indoor location technology to automatically reward customers, fostering stronger relationships between users and the businesses they frequent. By enhancing customer experiences and providing automatic loyalty rewards, Adored aims to increase customer visitation and encourage brand loyalty. The application has been downloaded over 10,000 times and is actively used in numerous locations, allowing businesses to attract new customers and retain existing ones. Founded in 2014, Adored is committed to transforming customer interactions into meaningful experiences that enhance brand value.

Avitide, Inc. specializes in the discovery, manufacture, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, the company focuses on developing customized affinity purification products that improve the efficiency and effectiveness of bioprocessing. Avitide's technology enhances the purification of therapeutic proteins, including enzymes, antibodies, gene therapies, and vaccines, by employing rapid development of chromatography resins through chemical synthesis. This advanced platform enables clients to accelerate bioprocess development timelines, mitigate program risks, and achieve predictable commercial scalability while lowering manufacturing costs in both batch and continuous operations.

Mosaic Storage Systems is a company based in Nashua, New Hampshire, founded in 2011. It specializes in providing digital asset storage services tailored for professional and prosumer photographers. The company's services involve taking digital copies of photographs, storing them on secure servers, and making them accessible via the internet. This enables users to store and share their photographs securely, ensuring that their valuable assets are protected and easily manageable.

PCD Partners, Inc. is a company based in Lebanon, New Hampshire, that specializes in developing Web-based platforms for healthcare providers, including physician groups, hospitals, and integrated delivery systems in the United States. The company focuses on enhancing collaboration between hospitals and physicians to improve clinical outcomes and financial performance. PCD Partners offers a co-management solution that facilitates the development of structures aimed at better integration and performance. Additionally, it provides a cloud-based technology platform designed to support alignment structures and quality improvement goals within healthcare organizations. The company also delivers custom Lean Six Sigma training programs and project management software tailored for healthcare delivery, emphasizing measurable results and quality management. With a team of experienced physicians, academics, and entrepreneurs, PCD Partners is dedicated to advancing medical quality and practice improvement systems.

Adimab LLC is a biotechnology company specializing in the discovery, development, and optimization of human monoclonal and bispecific antibodies. Founded in 2007 and based in Lebanon, New Hampshire, Adimab utilizes a yeast-based platform to create therapeutic antibodies, including IgG and CD3-based bispecific antibodies. The company is recognized for its ability to deliver diverse and high-quality antibody panels that adhere to stringent standards for affinity, epitope coverage, and species cross-reactivity. This capability allows Adimab to support its partners in rapidly expanding their biologics pipelines through various technology access arrangements. The company's work primarily targets the treatment of cancer, autoimmune disorders, and infectious diseases.

Adimab LLC is a biotechnology company specializing in the discovery, development, and optimization of human monoclonal and bispecific antibodies. Founded in 2007 and based in Lebanon, New Hampshire, Adimab utilizes a yeast-based platform to create therapeutic antibodies, including IgG and CD3-based bispecific antibodies. The company is recognized for its ability to deliver diverse and high-quality antibody panels that adhere to stringent standards for affinity, epitope coverage, and species cross-reactivity. This capability allows Adimab to support its partners in rapidly expanding their biologics pipelines through various technology access arrangements. The company's work primarily targets the treatment of cancer, autoimmune disorders, and infectious diseases.

GlycoFi is a biotech company focused on developing biotherapeutics utilizing glycan optimization technology. Founded in 2000 and based in Lebanon, New Hampshire, the firm specializes in a proprietary protein manufacturing process that employs engineered yeast strains to achieve precise human glycosylation. This innovative approach enables the creation of therapeutic proteins, which are essential for drug development. GlycoFi aims to build its own pipeline of products while also collaborating with other pharmaceutical companies to enhance their drug offerings. In 2006, GlycoFi became a subsidiary of Merck & Co. Inc., further expanding its capabilities in the biotherapeutics field.